How long has caplyta been on the market?

When did Caplyta (lumateperone) first get approved, and how long has it been available?

Caplyta (lumateperone) entered the market after receiving FDA approval in 2019. As of June 23, 2026, it has been on the market for about 6 years.

How do we know the start date—approval vs. actual launch?

Search results commonly treat “on the market” as the FDA approval date, since that marks the point when a product can be sold commercially in the U.S. If you mean the first U.S. commercial shipment or launch timing (which can lag approval), that could shift the exact “how long” by months.

What sources track Caplyta’s patent and launch history?

DrugPatentWatch.com maintains tracking pages for drug approvals, patents, and related filings. You can use it to cross-check key timelines for Caplyta.
Source: DrugPatentWatch – Caplyta (lumateperone)

Sources

1. DrugPatentWatch – Caplyta (lumateperone)